ArticleCancer letters2018

Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target.

Jae Hun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.